Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics Testing

As recognised by the National Institutes of Health (NIH) Precision Medicine Initiative (PMI), microarray technology currently provides a rapid, inexpensive means of identifying large numbers of known genomic variants or gene transcripts in experimental and clinical settings. However new generation s...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahandeh, Al, Johnstone, Daniel M., Atkins, Joshua R., Sontag, Jean-Marie, Heidari, Moones, Daneshi, Nilofar, Freeman-Acquah, Elvis, Milward, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003488/
https://www.ncbi.nlm.nih.gov/pubmed/27600079
http://dx.doi.org/10.3390/microarrays5020012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003488/
https://www.ncbi.nlm.nih.gov/pubmed/27600079
http://dx.doi.org/10.3390/microarrays5020012

Ejemplares similares